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• The American Society of Clinical Oncology launched
CancerLinQ project in 2010.
• CancerLinQ provides real-time data collection, mining and
visualization, clinical decision support, and quality feedback.
• Creation of a big data software platform is currently underway to
power the CancerLinQ in the phase II of the project.
• This would allow for evidence driven practice and rapid learning
for cancer care providers.
• Adequate knowledge about the utility of Big Data to encourage
provider utilization is needed.
• This is mainly achieved by increasing the publication trend in Big
Data.
• It is especially important that publications are in specialized
journals to target the right audience.
• It is also equally important to have an increased amount of
publications in high impact factor (IF) journals.
• We aimed to assess trends and quality of Big Data published in
Oncology.
Methods
• A systematic search of PubMed® for English publications from
2011 to 2015 using cancer and Big Data query was conducted.
• Manual review of manuscripts was performed in order to select
appropriate articles that actually discuss big data in the field of
oncology.
• Data collected included publication type, study design, cancer
subtype, publication year, journal category, sample size if
applicable, location, VA vs non-VA, first and corresponding
author names, whether it is funded or not, having a federal fund
if applicable, whether any author holds a Bioinformatics degree,
the software used, the journal name and its impact factor.
• Statistical analysis included descriptive analysis of findings in a
cohort design.
• The percentage of publications in each year was calculated and
a trend of the number of publications was drawn.
• Journals were categorized between basic sciences and clinical.
• The average impact factor of journals from each year was
calculated and the trend of impact factor was assessed.
• The contribution of specialized journals to publications was also
assessed.
• The US-based versus international contribution was compared.
• Some of the software used were reported.
• The Percentage of funded research was calculated.
Results
• We identified 325 publications
• 135 met inclusion criteria in 105 journals, of which 36% (n=38)
are considered specialized hematology and/or oncology
journals.
• Specialized journals published 29.62% (40/135).
• Equal distribution of publications was found in clinical and
basic science journals; 54 (37%) and 50 (40%) respectively.
• There was a trend of increased publications in clinical journals
from 2012 to 2015 (16.7% to 42.9%, P = 0.39).
• Of the available Impact factors (IF)–the median is 3.234 (range
0.00-41.456).
• 25/125 (20.0%) of available IF is > 5.00 and 12/125 (9.6%) is
>10.00 with no difference in the proportion of IF > 5.00 in
clinical versus basic science journals; 11/51 (21%) versus 11/47
(23) % p = 1.00, respectively.
Conclusion
• The need for further publication of studies addressing Big Data
use in furthering oncology research is being met by the research
community in response to the CancerLinQ as demonstrated by
the rapid increase in publications.
• We hypothesize that this will increase the likelihood of cancer
providers using CancerLinQ in the future
• An increase in publication in specialized journals and in those
with high impact factors is still necessary.
• Currently, despite the increased trend of publications addressing
Big Data in oncology, less than one-third of these publications
are in specialized journals.
Figure1: Distribution of Publications Among 


































Clinical and Basic science
Impact Factor 2011-12 2013 2014 2015 Total
<0.15 2 1 4 4 11
0.15-1.0 1 0 1 0 2
1.01-2.50 1 1 9 15 26
2.51-5.0 2 6 23 28 59
>5.0 0 4 12 9 25

































There is an equal distribution of
publications among basic
science and clinical journals
with a small proportion being
published in journals that are





























Table1: Number of Yearly Publications in Each 
Impact Factor Category
The total number of publications is consistently increasing from one
year to another since 2011. Moreover, there is an increasing number
of publications belonging to a higher impact.
Figure3: Location of 
Publications
There are more publications
based in the United States than
in outside countries together.
Figure4: Comparison 
of Funded and Non-
Funded Research
More studies are funded
worldwide than non-funded.
